Outcome of patients treated with pentostatin as salvage therapy of steroid refractory acute intestinal graft-versus-host disease

被引：0
作者：
Klein, SA [1 ]
Bug, G [1 ]
Wassmann, B [1 ]
Hoelzer, D [1 ]
Martin, H [1 ]
机构：
[1] Univ Frankfurt Klinikum, D-6000 Frankfurt, Germany
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [42] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [43] Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
    Faraci, Maura
    Calevo, Maria Grazia
    Giardino, Stefano
    Leoni, Massimiliano
    Ricci, Erica
    Castagnola, Elio
    Lanino, Edoardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 743 - 748
  • [44] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [45] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [46] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
  • [47] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [48] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [49] Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
    Brittany Knick Ragon
    Rohtesh S. Mehta
    Alison M. Gulbis
    Rima M. Saliba
    Julianne Chen
    Gabriela Rondon
    Uday R. Popat
    Yago Nieto
    Betul Oran
    Amanda L. Olson
    Krina Patel
    Chitra M. Hosing
    Muzaffar H. Qazilbash
    Nina Shah
    Partow Kebriaei
    Elizabeth J. Shpall
    Richard E. Champlin
    Amin M. Alousi
    Bone Marrow Transplantation, 2018, 53 : 315 - 325
  • [50] Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
    Ragon, Brittany Knick
    Mehta, Rohtesh S.
    Gulbis, Alison M.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Popat, Uday R.
    Nieto, Yago
    Oran, Betul
    Olson, Amanda L.
    Patel, Krina
    Hosing, Chitra M.
    Qazilbash, Muzaffar H.
    Shah, Nina
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Alousi, Amin M.
    BONE MARROW TRANSPLANTATION, 2018, 53 (03) : 315 - 325
12345